Kinney Horn's most recent trade in Immunome Inc was a trade of 130,000 Stock option (right to buy) done . Disclosure was reported to the exchange on Aug. 9, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 130,000 | 130,000 | - | - | Stock option (right to buy) | |
| Immunome Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 300,000 | 300,000 | - | - | Stock option (right to buy) | |
| Olema Pharmaceuticals Inc | Kinney Horn | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 4.75 per share. | 10 Mar 2022 | 5,253 | 2,458 | - | 4.8 | 24,952 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2022 | 5,253 | 141,785 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 10 Mar 2022 | 5,253 | 7,711 | - | 2.1 | 10,842 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 5,251 | 147,038 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 10 Feb 2022 | 5,251 | 7,709 | - | 2.1 | 10,838 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Feb 2022 | 5,251 | 2,458 | - | - | Common Stock | |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 133,000 | 133,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 6.85 per share. | 10 Jan 2022 | 5,251 | 2,458 | - | 6.8 | 35,969 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2022 | 5,251 | 152,289 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 10 Jan 2022 | 5,251 | 7,709 | - | 2.1 | 10,838 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 10 Dec 2021 | 5,251 | 7,709 | - | 2.1 | 10,838 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2021 | 5,251 | 157,540 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 10.39 per share. | 10 Dec 2021 | 5,251 | 2,458 | - | 10.4 | 54,558 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 26.88 per share. | 10 Nov 2021 | 27,668 | 1,790 | - | 26.9 | 743,716 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.00 per share. | 10 Nov 2021 | 22,417 | 29,458 | - | 19 | 425,923 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2021 | 22,417 | 67,253 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2021 | 5,251 | 162,791 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 10 Nov 2021 | 5,251 | 7,041 | - | 2.1 | 10,838 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2021 | 5,251 | 168,042 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 11 Oct 2021 | 5,251 | 7,041 | - | 2.1 | 10,838 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 28.19 per share. | 11 Oct 2021 | 3,146 | 1,790 | - | 28.2 | 88,686 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 27.47 per share. | 11 Oct 2021 | 2,105 | 4,936 | - | 27.5 | 57,824 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 29.38 per share. | 10 Sep 2021 | 5,251 | 1,790 | - | 29.4 | 154,274 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2021 | 5,251 | 173,293 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 10 Sep 2021 | 5,251 | 7,041 | - | 2.1 | 10,838 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 5,251 | 178,544 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 10 Aug 2021 | 5,251 | 7,041 | - | 2.1 | 10,838 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 25.70 per share. | 10 Aug 2021 | 5,191 | 1,850 | - | 25.7 | 133,409 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 26.17 per share. | 10 Aug 2021 | 60 | 1,790 | - | 26.2 | 1,570 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2021 | 5,251 | 183,795 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 12 Jul 2021 | 5,251 | 7,041 | - | 2.1 | 10,838 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 26.33 per share. | 12 Jul 2021 | 3,859 | 3,182 | - | 26.3 | 101,607 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 27.00 per share. | 12 Jul 2021 | 1,392 | 1,790 | - | 27 | 37,584 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 10 Jun 2021 | 5,251 | 7,041 | - | 2.1 | 10,838 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2021 | 5,251 | 189,046 | - | - | Stock Option (right to buy) | |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 29.97 per share. | 10 Jun 2021 | 2,787 | 1,790 | - | 30.0 | 83,526 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 29.60 per share. | 10 Jun 2021 | 2,164 | 4,577 | - | 29.6 | 64,054 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 28.30 per share. | 10 Jun 2021 | 300 | 6,741 | - | 28.3 | 8,490 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.06 per share. | 18 May 2021 | 57,763 | 59,553 | - | 2.1 | 119,223 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2021 | 57,763 | 194,297 | - | - | Stock Option (Right to Buy) | |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 24.03 per share. | 18 May 2021 | 49,142 | 10,411 | - | 24.0 | 1,180,882 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 24.81 per share. | 18 May 2021 | 8,621 | 1,790 | - | 24.8 | 213,887 | Common Stock |
| Olema Pharmaceuticals Inc | Kinney Horn | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) |